dMed Biopharmaceutical

Business Services · New York, United States · 501-1,000 Employees

View Company Info for Free

Overview

Headquarters

261 Madison Ave Fl 24, New York, New Yor...

Phone Number

(212) 681-2100

Revenue

$202.5 Million

Industry

Business Services Research & Development

About dMed Biopharmaceutical

Caidya is a global clinical research service provider that partners with biopharmaceutical innovation companies to deliver professional clinical trial expertise and agile capabilities for complex trials. With over 20 years of experience, they offer flexible, patient-centered clinical trial solutions, ensuring high-quality data delivery while reducing risks. Their unique global presence allows them to reach patient populations across more than 40 countries, supporting innovative breakthroughs and clinical achievements. Caidya focuses on aligning with client goals to provide valuable insights for future advancements in clinical research.Explore more
dMed Biopharmaceutical's Social MediaSIC Code 87,873NAICS Code 54,541Show more

dMed Biopharmaceutical Org Chart

PhoneEmail
CB
United States flag for contact location.

Global Controller

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
YW
United States flag for contact location.

Senior Manager, Finance

PhoneEmail
XZ
United States flag for contact location.

Senior Manager, Financial Planning & Analysis

PhoneEmail
CS
United States flag for contact location.

Manager, Finance Analysis

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to dMed Biopharmaceutical

Compare insights from companies similar to dMed Biopharmaceutical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

dMed Biopharmaceutical

$202.5M
501-1,000
Private
$158M
2016
CB
Candy BaoGlobal Controller
$198.5M
1K - 5K
Private
-
1966
$183.5M
1K - 5K
Private
-
2010
Susan Thornton, President & Chief Executive Officer at Celerion
Susan ThorntonPresident & CEO
$118.1M
201-500
Private
<$5M
2011
NS
Naga ShankarHead of Supply Chain
$105.2M
501-1,000
Private
<$5M
1994
$61.4M
51-200
Private
-
1967
MF
Michael FantFinancial Controller
$29M
201-500
Private
-
1996
MO
Mark O'DonnellVice President, Sales & Marketing
Illustration of an envelope

dMed Biopharmaceutical Tech Stack

A closer look at the technologies used by dMed Biopharmaceutical

Top Business Services Companies

Frequently Asked Questions Regarding dMed Biopharmaceutical

What is dMed Biopharmaceutical's official website?
dMed Biopharmaceutical's official website is www.dmedglobal.com
What is dMed Biopharmaceutical's Revenue?
dMed Biopharmaceutical's revenue is $202.5 Million
What is dMed Biopharmaceutical's SIC code?
dMed Biopharmaceutical's SIC: 87,873
What is dMed Biopharmaceutical's NAICS code?
dMed Biopharmaceutical's NAICS: 54,541
How many employees does dMed Biopharmaceutical have?
dMed Biopharmaceutical has 501-1,000 employees
What industry does dMed Biopharmaceutical belong to?
dMed Biopharmaceutical is in the industry of: Business Services, Research & Development
What is dMed Biopharmaceutical competition?
dMed Biopharmaceutical top competitors include: Global Pharma Tek, Siro Clinpharm Pvt, Avanti Research, Celerion
What companies has dMed Biopharmaceutical acquired?
dMed Biopharmaceutical has acquired the companies: Simbec, Paragon Biomedical, Worldwide Clinical Research, Regulus Pharmaceutical Consulting
What technology does dMed Biopharmaceutical use?
Some of the popular technologies that dMed Biopharmaceutical uses are: Jira, Mimecast, ASP.NET, jQuery
How do I contact dMed Biopharmaceutical?
dMed Biopharmaceutical contact info: Phone number: (212) 681-2100 Website: www.dmedglobal.com
What does dMed Biopharmaceutical do?

Caidya is a global clinical research service provider that partners with biopharmaceutical innovation companies to deliver professional clinical trial expertise and agile capabilities for complex trials. With over 20 years of experience, they offer flexible, patient-centered clinical trial solutions, ensuring high-quality data delivery while reduci... ng risks. Their unique global presence allows them to reach patient populations across more than 40 countries, supporting innovative breakthroughs and clinical achievements. Caidya focuses on aligning with client goals to provide valuable insights for future advancements in clinical research.Read More

What are dMed Biopharmaceutical social media links?
dMed Biopharmaceutical Linkedin page
Who invested in dMed Biopharmaceutical?
dMed Biopharmaceutical has 11 investors including Qiming Venture Partners, Qiming Venture Capital, Zai Lab and Tairui Investment.
Is dMed Biopharmaceutical a public company?
dMed Biopharmaceutical is private company therefore does not currently have an official ticker symbol
See more information about dMed Biopharmaceutical

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.